Among the likely beneficiaries, Laurus Labs and Biocon have been assigned a high probability of moving from the MSCI India Small Cap Index to the MSCI India Standard Index.
The August MSCI rebalancing is expected to generate over Rs 30,000 crore in inflows into India. Laurus Labs and Biocon are prominent contenders, highly probable to transition from the MSCI India Small Cap Index to the MSCI India Standard Index. This significant index shift could…
Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.